| Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China J Zhang, M Litvinova, Y Liang, Y Wang, W Wang, S Zhao, Q Wu, S Merler, ... Science 368 (6498), 1481-1486, 2020 | 1258 | 2020 |
| Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study J Zhang, M Litvinova, W Wang, Y Wang, X Deng, X Chen, M Li, W Zheng, ... The Lancet Infectious Diseases 20 (7), 793-802, 2020 | 793 | 2020 |
| Evaluation of the safety profile of COVID-19 vaccines: a rapid review Q Wu, MZ Dudley, X Chen, X Bai, K Dong, T Zhuang, D Salmon, H Yu BMC medicine 19, 1-16, 2021 | 280 | 2021 |
| Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind … G Zeng, Q Wu, H Pan, M Li, J Yang, L Wang, Z Wu, D Jiang, X Deng, ... The Lancet Infectious Diseases 22 (4), 483-495, 2022 | 279 | 2022 |
| Modeling transmission of SARS-CoV-2 omicron in China J Cai, X Deng, J Yang, K Sun, H Liu, Z Chen, C Peng, X Chen, Q Wu, ... Nature medicine 28 (7), 1468-1475, 2022 | 267 | 2022 |
| Psychological responses, behavioral changes and public perceptions during the early phase of the COVID-19 outbreak in China: a population based cross-sectional survey M Qian, Q Wu, P Wu, Z Hou, Y Liang, BJ Cowling, H Yu MedRxiv, 2020.02. 18.20024448, 2020 | 231 | 2020 |
| Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study W Wang, Q Wu, J Yang, K Dong, X Chen, X Bai, X Chen, Z Chen, ... bmj 371, 2020 | 180 | 2020 |
| Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China J Yang, X Chen, X Deng, Z Chen, H Gong, H Yan, Q Wu, H Shi, S Lai, ... Nature communications 11 (1), 5411, 2020 | 112 | 2020 |
| Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity S Han, J Cai, J Yang, J Zhang, Q Wu, W Zheng, H Shi, M Ajelli, XH Zhou, ... Nature communications 12 (1), 4673, 2021 | 103 | 2021 |
| Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021 J Yang, V Marziano, X Deng, G Guzzetta, J Zhang, F Trentini, J Cai, ... Nature human behaviour 5 (8), 1009-1020, 2021 | 99 | 2021 |
| Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized … H Pan, Q Wu, G Zeng, J Yang, D Jiang, X Deng, K Chu, W Zheng, F Zhu, ... MedRxiv, 2021.07. 23.21261026, 2021 | 87 | 2021 |
| Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine Y Cao, X Hao, X Wang, Q Wu, R Song, D Zhao, W Song, Y Wang, ... Cell research 32 (1), 107-109, 2022 | 80 | 2022 |
| Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China J Zhang, M Litvinova, Y Liang, Y Wang, W Wang, S Zhao, Q Wu, S Merler, ... medrxiv, 2020 | 80 | 2020 |
| Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants induced by natural infection or vaccination: a systematic review and … X Chen, Z Chen, AS Azman, R Sun, W Lu, N Zheng, J Zhou, Q Wu, ... Clinical Infectious Diseases 74 (4), 734-742, 2022 | 71 | 2022 |
| Anxiety levels, precautionary behaviours and public perceptions during the early phase of the COVID-19 outbreak in China: a population-based cross-sectional survey M Qian, Q Wu, P Wu, Z Hou, Y Liang, BJ Cowling, H Yu BMJ open 10 (10), e040910, 2020 | 61 | 2020 |
| Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: A systematic review and individual data meta-analysis X Chen, Z Chen, AS Azman, R Sun, W Lu, N Zheng, J Zhou, Q Wu, ... | 58 | 2021 |
| Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study J Zhang, M Litvinova, W Wang, Y Wang, X Deng, X Chen, M Li, W Zheng, ... MedRxiv, 2020 | 49 | 2020 |
| Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study Z Chen, W Zheng, Q Wu, X Chen, C Peng, Y Tian, R Sun, J Dong, ... BMC medicine 20 (1), 130, 2022 | 42 | 2022 |
| A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase … M Li, J Yang, L Wang, Q Wu, Z Wu, W Zheng, L Wang, W Lu, X Deng, ... MedRxiv, 2021.08. 03.21261544, 2021 | 39 | 2021 |
| Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint X Chen, W Wang, X Chen, Q Wu, R Sun, S Ge, N Zheng, W Lu, J Yang, ... BMC medicine 20 (1), 36, 2022 | 27 | 2022 |